 |
 | |
 |  |
| We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level. |
Mission (from advancedbiotherapy.com) “Advanced Biotherapy, Inc. is dedicated to developing effective antibody-based treatments for those who suffer from certain autoimmune diseases.” Company Profile We have now identified and patented the use of antibodies to interferon-gamma (IFN-g) as a monotherapy, and gamma interferon in combination with other antibodies, to treat multiple diseases. We are beginning the process of discussing licensing and co-development opportunities with appropriate candidate companies. The Company’s scientific founder, Dr. Simon Skurkovich, was the first to propose the use of antibodies to treat certain autoimmune disease by the removal of certain immune system agents called cytokines. This therapeutic strategy has now received universal validation by the biotechnology industry as evidenced by numerous publications and research supporting the work of Dr. Skurkovich. The Company has generated preliminary clinical data in almost 250 patients demonstrating the potential safety and efficacy of its treatment protocols in these disease states. © 2003 Advancedbiotherapy.com. All rights reserved. | ||||||||||||||
|
| Home | Hot | SubjectMarks | PeopleMarks | Keepers | Settings |
| Terms Of Use | Contact Us | Copyright/IP Policy | Privacy Policy | About Us | FAQ | Advertise on SI |
| © 2026 Knight Sac Media. Data provided by Twelve Data, Alpha Vantage, and CityFALCON News |